Xenocor Scores Fourth U.S. Patent for Novel Saberscope System

The Saberscope system is FDA cleared for use in laparoscopic and thoracoscopic surgery.

I Stock 530685117
iStock

Xenocor, a Utah-based medical device company, today announced newly issued U.S. patent protection for the Saberscope system from the United States Patent and Trademark Office (USPTO).

The Saberscope system is an HD, fog free, omnidirectional articulating, recyclable laparoscope.

Saberscope's disposable design sets itself apart by minimizing unnecessary patient risk, hassles, cost, workflow complexity and waste. Traditional laparoscopes can expose patients to potential cross contamination and cause OR fires and arc injuries. They are also prone to fogging and have a limited visual field due to lack of articulation.

The Saberscope system is a disposable 5mm scope, so there is no risk of cross contamination. It is non-conducting and does not get hot enough to initiate combustion. It is brand new out of the box every time, is completely fog free and sees better through smoke and steam. It articulates to 90 degrees in every direction, requires little to no capital costs and requires no complex setup or sterilization logistics. Lastly, it is recyclable and creates less landfill and water waste than traditional scopes.

The Saberscope system is FDA cleared for use in laparoscopic and thoracoscopic surgery. Xenocor's devices have been used in more than 300 live human cases.

More in Imaging